Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Nn i
Utilising our expertise and experience in medication adherence and patient compliance we acquire, monitor, analyse, guide and interpret data to deliver absolute clarity and bring confidence to sponsors, trialists, and ultimately, patients
In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet
Kaplowitz N
[PMID: 30686744] PubMed record related to this compound for laboratory literature review
Decreases also occurred in diastolic blood pressure, but were not statistically significant
US$ 21.08
US$ 29.47
US$ 25.40
US$ 29.11
US$ 29.51
